ArticleEndocrine-related cancer2011

Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer.

Adena E Rosenblatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.